Excellent Outcomes for Transcatheter Aortic Valve Replacement Within 1 Year of Opening a Low-Volume Centreand Consideration of Requirements

Canadian Journal of Cardiology

Volumn 30, Issue 12, 2014, Pages 1576-1582

  Chevalier, Florent ^a   Poulin, Frédéric ^a   Lamarche, Yoan ^a,b   Viet Le, Van Hoai ^a   Gallant, Mélanie ^a   Daoust, Anik ^a   Heylbroeck, Christophe ^a   Serri, Karim ^a   Beaulieu, Yanick ^a   Demers, Philippe ^a,b   El Hamamsy, Ismail ^a,b   Jeanmart, Hugues ^a,b   Pagé, Pierre ^a,b   Schampaert, Erick ^a   Palisaitis, Donald ^a   Généreux, Philippe ^a  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^b MONTREAL HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AORTA STENOSIS; ARTERY PERFORATION; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART VALVE PROSTHESIS; HIGH RISK PATIENT; HUMAN; LENGTH OF STAY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; OUTCOME ASSESSMENT; TRANSCATHETER AORTIC VALVE IMPLANTATION; VERY ELDERLY; AORTIC VALVE STENOSIS; FOLLOW UP; HEART CATHETERIZATION; LOW VOLUME HOSPITAL; PROCEDURES; PROSTHESIS; REGISTER; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME;

AGED, 80 AND OVER; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HOSPITALS, LOW-VOLUME; HUMANS; MALE; PROSTHESIS DESIGN; REGISTRIES; RETROSPECTIVE STUDIES; TIME FACTORS; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME;

EID: 84919772752     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.08.010     Document Type: Article

References (44)

1. Grube E., Schuler G., Buellesfeld L., et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. JAm Coll Cardiol 2007, 50:69-76.
2. Cribier A., Eltchaninoff H., Tron C., et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. JAm Coll Cardiol 2004, 43:698-703.
3. Lichtenstein S.V., Cheung A., Ye J., et al. Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation 2006, 114:591-596.
4. Webb J.G., Chandavimol M., Thompson C.R., et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006, 113:842-850.
5. Webb J.G., Pasupati S., Humphries K., et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007, 116:755-763.
6. Rodes-Cabau J., Webb J.G., Cheung A., et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicentre Canadian experience. JAm Coll Cardiol 2010, 55:1080-1090.
7. Thomas M., Schymik G., Walther T., et al. Thirty-day results of the SAPIEN aortic bioprosthesis (SOURCE) registry: a European registry of transcatheter aortic valve implantation using the EDWARDS SAPIEN valve. Circulation 2010, 122:62-69.
8. Moat N.E., Ludman P., de Belder M.A., et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: The U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. JAm Coll Cardiol 2011, 58:2130-2138.
9. Gilard M., Eltchaninoff H., Iung B., et al. Registry of transcatheter aortic-valve implantation in high-risk patients. NEngl J Med 2012, 366:1705-1715.
10. Mack M.J., Brennan J.M., Brindis R., et al. Outcomes following transcatheter aortic valve replacement in the United States. JAMA 2013, 310:2069-2077.
11. Linke A., Wenaweser P., Gerckens U., et al. Treatment of aortic stenosis with a self-expanding transcatheter valve: the International Multi-centre ADVANCE study. Eur Heart J 2014, 35(38):2672-2684.
12. Leon M.B., Smith C.R., Mack M., et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. NEngl J Med 2010, 363:1597-1607.
13. Smith C.R., Leon M.B., Mack M.J., et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. NEngl J Med 2011, 364:2187-2198.
14. Adams D.H., Popma J.J., Reardon M.J., et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. NEngl J Med 2014, 371:967-968.
15. Cribier A., Eltchaninoff H., Bash A., et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002, 106:3006-3008.
16. Gurvitch R., Tay E.L., Wijesinghe N., et al. Transcatheter aortic valve implantation: lessons from the learning curve of the first 270 high-risk patients. Cathet Cardiovasc Interv 2011, 78:977-984.
17. Toggweiler S., Gurvitch R., Leipsic J., et al. Percutaneous aortic valve replacement: vascular outcomes with a fully percutaneous procedure. JAm Coll Cardiol 2012, 59:113-118.
18. Alli O.O., Booker J.D., Lennon R.J., et al. Transcatheter aortic valve implantation: assessing the learning curve. JACC Cardiovasc Interv 2012, 5:72-79.
19. Feldman A.M., Disesa V.J. Transcatheter aortic valve replacement: flattening the cost curve. JAMA 2014, 312:25-26.
20. Kappetein A.P., Head S.J., Genereux P., et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. JAm Coll Cardiol 2012, 60:1438-1454.
21. Lang R.M., Bierig M., Devereux R.B., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. JAm Soc Echocardiogr 2005, 18:1440-1463.
22. Baumgartner H., Hung J., Bermejo J., et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. JAm Soc Echocardiogr 2009, 22:1-23. quiz 101-2.
23. Zamorano J.L., Badano L.P., Bruce C., et al. EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. JAm Soc Echocardiogr 2011, 24:937-965.
24. Carasso S., Biaggi P., Rakowski H., et al. Velocity Vector Imaging: standard tissue-tracking results acquired in normal-the VVI-STRAIN study. JAm Soc Echocardiogr 2012, 25:543-552.
25. Chevalier F., Leipsic J., Genereux P. Valve-in-valve implantation with a 23-mm balloon-expandable transcatheter heart valve for the treatment of a 19-mm stentless bioprosthesis severe aortic regurgitation using a strategy of"extreme" underfilling. Catheter Cardiovasc Interv 2014, 84:503-508.
26. Webb J., Rodes-Cabau J., Fremes S., et al. Transcatheter aortic valve implantation: a Canadian Cardiovascular Society position statement. Can J Cardiol 2012, 28:520-528.
27. Holmes D.R., Mack M.J., Kaul S., et al. 2012 ACCF/AATS/SCAI/STS Expert consensus document on transcatheter aortic valve replacement. JAm Coll Cardiol 2012, 59:1200-1254.
28. Van Belle E., Juthier F., Susen S., et al. Postprocedural aortic regurgitation in balloon-expandable and self-expandable transcatheter aortic valve replacement procedures: Analysis of predictors and impact on long-term mortality: Insights from the FRANCE2 registry. Circulation 2014, 129:1415-1427.
29. Barbanti M., Leipsic J., Binder R., et al. Underexpansion and ad hoc post-dilation in selected patients undergoing balloon-expandable transcatheter aortic valve replacement. JAm Coll Cardiol 2014, 63:976-981.
30. Hahn R.T., Khalique O., Williams M.R., et al. Predicting paravalvular regurgitation following transcatheter valve replacement: utility of a novel method for three-dimensional echocardiographic measurements of the aortic annulus. JAm Soc Echocardiogr 2013, 26:1043-1052.
31. Genereux P., Head S.J., Hahn R., et al. Paravalvular leak after transcatheter aortic valve replacement: The new Achilles' heel? A comprehensive review of the literature. JAm Coll Cardiol 2013, 61:1125-1136.
32. Kodali S.K., Williams M.R., Smith C.R., et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. NEngl J Med 2012, 366:1686-1695.
33. Poulin F, Carasso S, Horlick EM, etal. Recovery of left ventricular mechanics after transcatheter aortic valve implantation: effects of baseline ventricular function and postprocedural aortic regurgitation [epub ahead of print]. J Am Soc Echocardiogr , accessed November 16, 2014. doi:10.1016/j.echo.2014.07.001.
34. Binder R.K., Rodes-Cabau J., Wood D.A., et al. Transcatheter aortic valve replacement with the SAPIEN 3: a new balloon-expandable transcatheter heart valve. JACC Cardiovasc Interv 2013, 6:293-300.
35. Binder R.K., Schafer U., Kuck K.H., et al. Transcatheter aortic valve replacement with a new self-expanding transcatheter heart valve and motorized delivery system. JACC Cardiovasc Interv 2013, 6:301-307.
36. Genereux P., Reiss G.R., Kodali S.K., et al. Periaortic hematoma after transcatheter aortic valve replacement: description of a new complication. Cathet Cardiovasc Interv 2012, 79:766-776.
37. Genereux P., Webb J.G., Svensson L.G., et al. Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of Aortic Transcatheter Valve) trial. JAm Coll Cardiol 2012, 60:1043-1052.
38. Genereux P., Kodali S., Leon M.B., et al. Clinical outcomes using a new crossover balloon occlusion technique for percutaneous closure after transfemoral aortic valve implantation. JACC Cardiovasc Interv 2011, 4:861-867.
39. Genereux P., Head S.J., Van Mieghem N.M., et al. Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: A weighted meta-analysis of 3,519 patients from 16 studies. JAm Coll Cardiol 2012, 59:2317-2326.
40. Genereux P., Cohen D.J., Williams M.R., et al. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I trial (placement of aortic transcatheter valve). JAm Coll Cardiol 2014, 63:1100-1109.
41. Reynolds M.R., Magnuson E.A., Wang K., et al. Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (cohort B). Circulation 2012, 125:1102-1109.
42. Reynolds M.R., Magnuson E.A., Lei Y., et al. Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (cohort A). JAm Coll Cardiol 2012, 60:2683-2692.
43. Boothroyd L.J., Spaziano M., Guertin J.R., et al. Transcatheter aortic valve implantation: recommendations for practice based on a multidisciplinary review including cost-effectiveness and ethical and organizational issues. Can J Cardiol 2013, 29:718-726.
44. Abdel-Wahab M., Mehilli J., Frerker C., et al. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA 2014, 311:1503-1514.